Prevention of Hypoxemia During Apnea Testing: A Comparison of Oxygen Insufflation And Continuous Positive Airway Pressure
Overview
Authors
Affiliations
Background: Apnea testing is an essential step in the clinical diagnosis of brain death. Current international guidelines recommend placement of an oxygen (O) insufflation catheter into the endotracheal tube to prevent hypoxemia, but use of a continuous positive airway pressure (CPAP) valve may be more effective at limiting arterial partial pressure of O (PO) reduction.
Methods: We performed a multicenter study assessing consecutive apnea tests in 14 intensive care units (ICUs) in two cities utilizing differing protocols. In one city, O catheters are placed and arterial blood gases (ABGs) performed at intervals determined by the attending physician. In the other city, a resuscitation bag with CPAP valve is attached to the endotracheal tube, and ABGs performed every 3-5 min. We assessed arterial PO, partial pressure of carbon dioxide (PCO), pH, and blood pressure at the beginning and termination of each apnea test.
Results: Thirty-six apnea tests were performed using an O catheter and 50 with a CPAP valve. One test per group was aborted because of physiological instability. There were no significant differences in the degree of PO reduction (-59 vs. -32 mmHg, p = 0.72), rate of PCO rise (3.2 vs. 3.9 mmHg per min, p = 0.22), or pH decline (-0.02 vs. -0.03 per min, p = 0.06). Performance of ABGs at regular intervals was associated with shorter test duration (10 vs. 7 min, p < 0.0001), smaller PCO rise (30 vs. 26 mmHg, p = 0.0007), and less pH reduction (-0.20 vs. -0.17, p = 0.0012). Lower pH at completion of the apnea test was associated with greater blood pressure decline (p = 0.006).
Conclusion: Both methods of O supplementation are associated with similar changes in arterial PO and PCO. Performance of ABGs at regular intervals shortens apnea test duration and may avoid excessive pH reduction and consequent hemodynamic effects.
Merchant R, Ahmad S, Haddix B, Williamson C, Jacobs T, Singh T Neurocrit Care. 2024; 42(1):312-313.
PMID: 39653976 DOI: 10.1007/s12028-024-02180-2.
Lambeck J, Bardutzky J, Strecker C, Niesen W Neurocrit Care. 2024; 41(3):1038-1046.
PMID: 38951444 PMC: 11599285. DOI: 10.1007/s12028-024-02035-w.
Apnea Testing on Conventional Mechanical Ventilation During Brain Death Evaluation.
Merchant R, Ahmad S, Haddix B, Williamson C, Jacobs T, Singh T Neurocrit Care. 2024; 41(2):426-433.
PMID: 38664328 PMC: 11377646. DOI: 10.1007/s12028-024-01990-8.
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline.
Greer D, Kirschen M, Lewis A, Gronseth G, Rae-Grant A, Ashwal S Neurology. 2023; 101(24):1112-1132.
PMID: 37821233 PMC: 10791061. DOI: 10.1212/WNL.0000000000207740.
Brain death: a clinical overview.
Spears W, Mian A, Greer D J Intensive Care. 2022; 10(1):16.
PMID: 35292111 PMC: 8925092. DOI: 10.1186/s40560-022-00609-4.